Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Belash, Z. Mironova, V. Trofimov, A. Ulitina, M. Zaraiski (Saint-Petersburg, Russian Federation). Pharmacogenetic and clinicopathological markers of BA-COPD (overlap syndrome). Eur Respir J 2014; 44: Suppl. 58, 3398

Member's Comments

No comment yet.

Related content which might interest you: Phenotypic and molecular-genetic features of asthma-COPD overlap syndrome (ACOS) Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015 Metabolic syndrome in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014 Impact of the genetic variation of GLCCI1 on clinical features of asthmatic patinets Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 Relationship between gene polymorphism in FGF10 and susceptibility to 220 patients with COPD Source: International Congress 2014 – COPD physiopathology Year: 2014 COPD and depression: Prevalence and interaction Source: International Congress 2014 – Comorbidities Year: 2014 Phenotypic characterization of asthma-COPD overlap syndrome: Comparison with asthma and COPD Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 A cross-sectional study on association between stable COPD & metabolic syndrome (Syndrome X) Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Clinical characteristics of the overlap syndrome of asthma and COPD in older adults Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 The asthma-COPD, overlap syndrome, our clinical experience Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Characteristics of essential hypertension in COPD patients Source: International Congress 2014 – COPD: points to ponder Year: 2014 The distribution of phenotypes in a population of severe COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Stable state MR-proadrenomedullin level in COPD patients; a validation study Source: International Congress 2014 – Comorbidities Year: 2014 Clinical, functional and laboratory assessment of treatment efficacy in COPD patients Source: International Congress 2014 – Predictors Year: 2014 Asthma-COPD overlap syndrome (ACOS) versus ²pure² COPD: A distinct phenotype? Source: International Congress 2016 – Best abstracts in asthma and COPD Year: 2016 Paradoxical response to bronchodilators: Radiologic correlates and clinical implications Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases Year: 2014 Clustering analysis of clinical variables in U-BIOPRED adult asthma cohort Source: International Congress 2014 – Asthma: still a heterogeneous condition! Year: 2014 ANCA associated vasculitis – Evaluation of diagnosis, treatment and outcome in a group of 68 patients Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014 Individual dynamic of inflammatory markers as indicators of COPD treatment effectiveness Source: International Congress 2014 – COPD: points to ponder Year: 2014 Clinical and pathophysiological features of asthma phenotypes Source: Annual Congress 2013 –Asthma at the bedside Year: 2013 Asthma phenotyping: Correlation between inflammatory phenotype, clinical parameters and associated comorbidities Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012